A Comparative Study on the Efficiency of CRISPR-Cas۹ in Human Embryonic Kidney ۲۹۳ Cells and Peripheral Blood Mononuclear Cells for Disruption in Programmed Cell Death Protein ۱

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 207

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_SGR-8-1_012

تاریخ نمایه سازی: 9 اسفند 1400

چکیده مقاله:

CRISPR-Cas۹ is the most important tool in genome engineering in recent years. The efficiency of this instrument on active and non-active genes is variable. Programmed cell death protein ۱(PD-۱) is a surface acceptor on T cells, B cells, and dendritic cells. This protein has an important role in the production of inducing tolerance in lymphocytes. Nowadays, this characteristic is used in cell therapy and immunotherapy of cancer. In the present study, the peripheral blood mononuclear cells and HEK۲۹۳ cells were selected as expression and non-expression cells of the PD-۱ gene. Six pairs of sgRNA were designed for the PD-۱ gene. The transfected cells were sorted by the FACS machine. A common pair of primers were used for amplification of cute regions. Px۴۵۸ was used as an expressional vector for the transfection of PBMCs and HEK۲۹۳. Transfection was done using lipofectamine and electroporation methods. In PBMCs, ۲ guides, sgRNA (۳+۱) and sgRNA (۳+۵) were able to disrupt the PD-۱ gene. In contrast, in HEK۲۹۳, none of the ۶ guides were able to disrupt it. According to the results obtained, the PD-۱ gene cutting in HEK۲۹۳ cells was failed. However, it was successful in PBMCs. Therefore, it can be told that the heterochromatin region or other genome remodeling mechanisms such as epigenetic remodeling inhibit the PD-۱ gene cutting by CRISPR-Cas۹ in HEK۲۹۳ cells.

نویسندگان

Seyed Ali Alambeladi

Department of Genetics, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran

Mehdi Dianatpour

Department of Medical Genetics, School of Medicine, Shiraz University of Medical Sciences, Shiraz Iran

Mojtaba jafarinia

Department of Genetics, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Alambeladi S, Hosseiny S, Jafarinia M, Dianatpour M. ۲۰۲۱. Use ...
  • Bally AP, Austin JW, Boss JM. ۲۰۱۶. Genetic and epigenetic ...
  • Blank C, Kuball J, Voelkl S, Wiendl H, Becker, B, ...
  • Cho SW, Kim S, Kim JM, Kim JS. ۲۰۱۳. Targeted ...
  • Cong L, Ran FA, Cox D, Lin S, Barretto R, ...
  • Cong L, Zhang F. Genome engineering using CRISPR-Cas۹ system. ۲۰۱۵. ...
  • Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, ...
  • John LB, Devaud C, Duong CP, Yong CS, Beavis PA, ...
  • Kallimasioti-Pazi EM, Thelakkad Chathoth K, Taylor GC, Meynert A, Ballinger ...
  • Keir ME, Butte MJ, Freeman GJ, Sharpe AH. ۲۰۰۸. PD-۱ ...
  • Lioyd A, Vickery ON, Laugel B. ۲۰۱۳. Beyond the antigen ...
  • Luke JJ, Ott PA. ۲۰۱۵. PD-۱ pathway inhibitors: the next ...
  • Makarova KS, Haft DH, Barrangou R, Brouns S J, Charpentier ...
  • Mali P, Yang L, Esvelt KM, Aach J, Guell M, ...
  • Pen JJ, Keersmaecker BD, Heirman C, Corthals J, Liechtenstein T, ...
  • Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, ...
  • Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, ...
  • Su S, Hu B, Shao J, Shen B, Du J, ...
  • Tumeh PC, Harview CL, Yearley JH, Shintaku I P, Taylor ...
  • Wang W, Lau R, Yu D, Zhu W, Korman A, ...
  • نمایش کامل مراجع